Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC


Caroline Tosch, et al.
Journal for ImmunoTherapy of Cancer, 2017, 5:70 – Download the article
Publication

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00 - Fax. : + 33 (0) 3 88 27 91 11

 

© 2018 Transgene - All rights reserved
Mentions légales - Crédits